-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App News, Guobang Pharmaceutical (605507.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved revenue of 3.142 billion yuan, an increase of 3.84%; net profit attributable to shareholders of listed companies was 341 million yuan, a year-on-year decrease of 25.07%; deducted non-net profit of 321 million yuan, a year-on-year decrease of 26.46%; and basic earnings per share were 0.44 yuan.

Zhitongcaijing·07/31/2026 10:25:10
Listen to the news
According to Zhitong Finance App News, Guobang Pharmaceutical (605507.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved revenue of 3.142 billion yuan, an increase of 3.84%; net profit attributable to shareholders of listed companies was 341 million yuan, a year-on-year decrease of 25.07%; deducted non-net profit of 321 million yuan, a year-on-year decrease of 26.46%; and basic earnings per share were 0.44 yuan.